The Pershing Square Sohn Cancer Research Alliance has announced the recipients of the 2020 Pershing Square Sohn Prize for Young Investigators.
Awarded to cancer research scientists and physician-scientists based in the greater New York area, the prize provides $200,000 annually for up to three years in support of research at a stage where traditional funding is lacking. In addition, recipients are invited to present their work to scientific and business audiences, helping to bridge the gap between academia and industry and across application domains.
This year's recipients include Vinod Balachandran (Memorial Sloan Kettering Cancer Center), who is working to identify effective immunotherapies for treating pancreatic cancer; Mohamed Abou Donia (Princeton University), who is researching novel computational and experimental approaches to the characterization of gut microbiome-derived small molecules that play a role in the etiology of colorectal cancer; Lydia Finley (Memorial Sloan Kettering), who is investigating how cancer cell metabolism affects pediatric malignancies; Shixin Liu (Rockefeller University), who is researching how specific gene mutations in particular histones and histone-modifying enzymes cause undesirable epigenetic changes that can lead to various diseases; and Britta Will (Albert Einstein College of Medicine / Montefiore Medical Center), who is examining the role of iron homeostasis regulatory pathways in leukemic stem cells.
"We remain committed to cancer research even during this global pandemic. We are extremely impressed by the superb quality of the proposals we received as well as the exceptionally talented researchers that are working in the greater New York-area institutions," said Olivia Tournay Flatto, co-founder and executive director of the Pershing Square Sohn Cancer Research Alliance and president of the Pershing Square Foundation. "It is our goal to build a community of innovative and talented individuals, and to connect them with a 'family' of funders and collaborators in pursuit of novel ideas, therapies, technologies, and, ultimately, knowledge that can further our understanding of disease and fundamental human biology."
For a complete list of award recipients, see the Pershing Square Sohn Cancer Research Alliance website.